Medicare Part D became more protective in 2025 and 2026, but that does not mean prescription costs became simple.
The old “donut hole” explanation is now outdated. In 2026, beneficiaries have a $2,100 annual out-of-pocket limit for covered Part D drugs, and once qualifying spending reaches that amount, covered Part D prescriptions generally have no additional cost sharing for the rest of the calendar year.
That is a significant improvement. Yet Part D can still produce financial surprises through deductibles, coinsurance, formulary tiers, pharmacy networks, prior authorization, changing plan designs, and the timing of expensive prescriptions.
The hidden costs are no longer concentrated in one notorious coverage gap. They are scattered throughout the plan.
The Donut Hole Is No Longer the Main Story
For years, Medicare Part D was commonly explained in four stages: deductible, initial coverage, coverage gap, and catastrophic coverage. Beneficiaries could move into the so-called donut hole after their total prescription spending reached a particular threshold.
That framework changed substantially beginning in 2025.
For 2026, the standard Part D benefit has a deductible of up to $615 and an annual out-of-pocket threshold of $2,100 for covered Part D drugs. Once the beneficiary reaches that threshold through qualifying spending, there is generally no additional cost sharing for covered Part D prescriptions for the rest of the year. CMS's current 2026 Part D structure reflects this redesigned benefit.
So the traditional donut-hole problem is no longer the right way to understand Part D costs.
That does not mean prescription spending disappears.
A beneficiary can still face hundreds or even thousands of dollars before reaching the cap, especially when expensive brand-name or specialty medications are involved.
Part D now puts a firmer ceiling on covered prescription spending, but the road to that ceiling can still be financially rough.
The practical question has shifted from “When will I enter the donut hole?” to “How will my plan make me pay before I reach the annual limit?”
The Premium Can Be the Least Important Number
Part D premiums are easy to compare because they are visible before enrollment.
Drug costs are harder.
A plan charging $10 per month can look much better than one charging $45. The annual premium difference is $420.
But suppose the $10 plan places one of your regular medications on a higher tier and charges substantial coinsurance. The $45 plan gives that same prescription a lower fixed copay.
The supposedly cheaper plan can become the more expensive choice after a few refills.
This is particularly important in 2026 because more beneficiaries are encountering prescription deductibles and percentage-based coinsurance. KFF's analysis of 2026 Part D cost sharing found that most Part D enrollees face either the standard $615 deductible or a partial deductible, while coinsurance is widely used for preferred brand, non-preferred, and specialty drugs.
Percentage-based cost sharing deserves attention because it behaves differently from a fixed copay.
A $40 copay is predictable.
Twenty-five percent of a medication's negotiated price can change significantly depending on the drug.
That difference is one of the places where Part D costs can remain difficult to forecast despite the annual cap.
6 Places Part D Costs Can Still Surprise You
1. The deductible may arrive before the benefit feels useful.
Not every plan applies its deductible identically to every drug tier.
Some plans may provide certain lower-tier generics without requiring the full deductible first. More expensive medications may be subject to the deductible immediately.
That creates a common January surprise.
A beneficiary who paid $15 for a medication late in the previous year may discover a much larger charge at the beginning of the new plan year because the deductible has reset.
The prescription did not necessarily become more expensive permanently. The beneficiary may simply be paying through the new year's deductible.
This is why January prescription costs should be checked before assuming the pharmacy made an error.
2. Coinsurance can make expensive medications unpredictable.
Copays give you a dollar amount.
Coinsurance gives you a percentage.
For a $20 generic, that distinction may barely matter. For a medication costing several thousand dollars, it matters considerably.
Suppose an expensive drug has a negotiated price of $2,000 and your plan requires 25% coinsurance during the applicable coverage phase.
Your share could be $500 for that fill.
Even though the $2,100 annual cap eventually limits qualifying Part D out-of-pocket spending, reaching it can happen quickly and painfully.
This is one reason a plan with a higher premium but better cost sharing can sometimes be the stronger option for someone using expensive prescriptions.
3. A covered drug can still come with restrictions.
Seeing a medication on the formulary is only the first check.
A plan may also require:
- Prior authorization
- Step therapy
- Quantity limits
- Use of a specialty pharmacy
- A particular formulation
- Other utilization-management requirements
Prior authorization can delay a refill while the prescriber submits information.
Step therapy may require another medication to be tried before the plan pays for the one originally prescribed, unless an exception is approved.
Quantity limits can affect how much medication is covered at one time.
None of these requirements automatically means the drug is excluded.
They do mean “covered” may involve more administrative work than expected.
4. The pharmacy can change the price.
Part D plans often use pharmacy networks that distinguish between preferred and standard participating pharmacies.
Both may accept the plan.
They do not necessarily charge you the same amount.
A medication might have favorable pricing at one pharmacy and substantially higher cost sharing at another under the same insurance policy.
This can become particularly confusing when someone has used the same neighborhood pharmacy for years and assumes that continued network participation means continued preferred pricing.
Check the pharmacy annually along with the drug.
Mail-order pricing also deserves comparison, particularly for maintenance medications. A 90-day supply may be advantageous under some plans, while another plan might offer comparable or better pricing at a preferred retail pharmacy.
Convenience matters too. A small saving is not always worth complicated transportation, unreliable delivery, or difficulty obtaining urgent refills.
5. Your medications can stay the same while the plan changes around them.
Part D plans can change from year to year.
Premiums may move.
Deductibles can change.
A medication can move to another formulary tier.
A pharmacy can lose preferred status.
Prior authorization or step-therapy requirements can change.
That means a plan that worked extremely well this year can become a poor fit next year even if your health and prescriptions remain almost identical.
The Annual Notice of Change deserves more attention than it usually receives.
During Medicare Open Enrollment, run your current prescriptions through the available plans again rather than assuming renewal is the safest choice.
6. Low monthly premiums can hide high early-year cash needs.
The $2,100 annual cap limits qualifying Part D spending, but it does not necessarily spread that spending evenly throughout the year.
Someone taking a very expensive drug could owe a large portion of the annual amount during the first few months.
That creates a cash-flow problem even if total annual spending is now capped.
The Medicare Prescription Payment Plan can help address this issue by allowing participants to spread eligible out-of-pocket Part D costs across monthly payments rather than paying large amounts at the pharmacy counter. The National Council on Aging's current explanation of the Medicare Prescription Payment Plan emphasizes an important limitation: spreading payments can make expenses easier to manage, but it does not reduce the underlying drug cost.
That distinction matters.
Paying $2,100 gradually can be much easier than paying much of it during the first quarter.
It is still $2,100.
Part D's annual cap solves part of the affordability problem. It does not automatically solve the cash-flow problem.
The Formulary Still Determines Whether the Cap Helps You
The $2,100 out-of-pocket limit applies to covered Part D prescription spending that counts under Medicare's rules.
That makes formulary status especially important.
If a medication is not covered by the plan and you simply purchase it outside the Part D benefit, that spending may not work the way you expect toward the annual Part D out-of-pocket limit.
The same caution applies when using outside discount arrangements.
A pharmacy discount price can sometimes be cheaper than using insurance, especially for inexpensive generics. But beneficiaries taking costly medications should understand whether a particular payment counts toward their Part D out-of-pocket total before assuming it does.
This creates a trade-off.
The cheapest price for one prescription today is not necessarily the option that produces the lowest total Part D spending across the entire year.
For someone taking only inexpensive generics, this may barely matter.
For someone likely to approach the $2,100 cap, it deserves much closer attention.
Manufacturer Coupons Are Not a Simple Medicare Strategy
Commercially insured patients often encounter manufacturer copay coupons for expensive brand-name medications.
Medicare beneficiaries face different rules.
Manufacturer assistance programs may have eligibility restrictions involving federal health coverage, and not every savings program can be used alongside Medicare Part D.
Do not build a plan comparison around a coupon without confirming that you are actually eligible to use it.
Other manufacturer patient-assistance programs can sometimes operate differently, as can independent charitable foundations, state pharmaceutical programs, and other forms of assistance.
The source of the help matters.
A discount that worked before Medicare enrollment may no longer work once Part D becomes the payer.
Extra Help Can Change the Entire Cost Picture
Beneficiaries with limited income and resources should not assume the standard Part D cost structure is what they must pay.
Medicare's Extra Help program can reduce Part D expenses, including premiums, deductibles, and prescription cost sharing for eligible beneficiaries.
Social Security allows people to apply for Extra Help before or after enrolling in Part D. Eligibility depends on income and resources, and some beneficiaries qualify automatically through other assistance programs.
This is one of the most important places to look before concluding that Medicare prescription coverage is unaffordable.
Someone taking several costly medications may spend significant effort comparing plans while overlooking a program that could materially change the entire calculation.
If you are uncertain whether you qualify, check rather than ruling yourself out based on a rough estimate.
A Higher-Premium Plan Can Still Be the Cheaper Plan
Consider a beneficiary taking five prescriptions.
Four are low-cost generics. The fifth is an expensive brand-name medication.
Plan A costs $8 per month.
Plan B costs $48.
Plan A therefore saves $480 annually in premiums.
But Plan A requires substantial coinsurance for the expensive medication and uses a pharmacy that is less favorable for two of the other prescriptions.
Plan B charges more each month but places the costly medication on better terms and offers favorable pricing at the beneficiary's regular pharmacy.
If the medication costs are high enough, Plan B can produce lower total annual spending despite charging six times the monthly premium.
Now change one fact.
Suppose the expensive medication is discontinued six months later.
Plan A may become the better deal again.
This is why there is no universally cheapest Part D plan.
The cheapest plan depends heavily on the medications you use now.
The Out-of-Pocket Cap Is Powerful, but It Does Not Replace Annual Shopping
The redesigned Part D benefit gives people with high prescription expenses much stronger protection than the old structure.
It should not encourage automatic renewal.
Plan design still influences how rapidly you spend toward the cap and how difficult the first part of the year feels.
Someone taking inexpensive medications may never approach $2,100.
For that person, premium, deductible, tier structure, and pharmacy pricing can determine almost the entire annual cost.
Someone taking specialty medication may reach the cap quickly. For them, cash-flow timing, formulary access, authorization rules, and whether the drug is actually covered can matter more.
The same $2,100 ceiling therefore affects different beneficiaries in very different ways.
Free Medicare Counseling Can Help With Complicated Comparisons
People taking multiple medications can end up comparing several plans, formularies, pharmacies, deductible structures, and utilization rules at once.
You do not have to work through that alone.
State Health Insurance Assistance Programs provide free, objective Medicare counseling. The Administration for Community Living explains that SHIP counselors can help beneficiaries compare Medicare prescription coverage, understand costs, apply for assistance programs, and work through enrollment questions.
Bring a complete medication list to the comparison.
Include the precise drug name, dosage, formulation, frequency, and preferred pharmacy.
The more accurate the medication list, the more meaningful the plan comparison becomes.
Part D shopping gets much easier when you stop comparing insurance plans in the abstract and start comparing what each plan does to the prescriptions sitting in your medicine cabinet.
The Quote Check!
Before treating a low-premium Part D plan as the inexpensive choice, look for the costs that do not appear in the headline price:
- Check the January Cost: Find out which medications face the deductible and estimate what your first few refills could cost after the benefit resets for the year.
- Check the Percentage Charges: Identify medications subject to coinsurance rather than fixed copays, especially expensive brand-name and specialty drugs.
- Check the Rules Behind “Covered”: Review prior authorization, step therapy, quantity limits, and specialty-pharmacy requirements for every important medication.
- Check Where You Fill It: Compare preferred, standard, mail-order, and required specialty pharmacies rather than assuming one network pharmacy costs the same as another.
- Check the Cash-Flow Plan: If expensive prescriptions could push you quickly toward the $2,100 annual limit, determine whether spreading payments through the Medicare Prescription Payment Plan would make the year easier to manage.
The Hidden Costs Moved; They Did Not Disappear
Medicare Part D is substantially different from the program that produced the famous donut hole. In 2026, the $2,100 out-of-pocket cap gives beneficiaries stronger protection against very high covered prescription costs, and the old coverage-gap explanation no longer captures how the benefit works.
But Part D still has financial pressure points.
The deductible can reset sharply in January. Coinsurance can make expensive drugs costly early in the year. Formularies and pharmacy networks can change. A covered drug may come with authorization rules. A low premium may hide substantially higher prescription spending.
The better comparison looks at Price, Coverage, Access, and Timing together.
Do not choose a Part D plan because its premium looks inexpensive or because it worked last year. Run your current prescriptions through the plan, check the pharmacy, inspect the restrictions, and understand when the money is likely to leave your pocket.
The old donut hole may be gone, but the need to read the drug benefit carefully is not.